title: Conformational basis for the activation of adenylate cyclase by adenosine.
abstract: The ability of adenosine to stimulate adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] and increase adenosine 3':5'-cyclic monophosphate (cAMP) levels has important biochemical consequences. These include the suppression of immune responses and cardiovascular effects. Recent investigations involving the ability of adenosine and adenosine analogs to stimulate adenylate cyclase provided experimental data that appear to be correlated with the ability of adenosine and analogs of adenosine to exist in the glycosidic high anti conformation. 9-beta-D-Arabinofuranosyladenine, which is not stable in the high anti conformation, is inactive as a stimulator of adenylate cyclase. 2'-Deoxyadenosine is also not stable in the high anti conformation but its instability may be significantly decreased by intramolecular adjustments promoted by receptor or active site interactions. 2'-Deoxyadenosine does not activate adenylate cyclase in lymphocytes when ATP is the substrate but is able to activate adenylate cyclase when 2-fluoro ATP is the substrate. The inability of certain analogs of adenosine, with bulky groups substituted for hydrogen at the 8 position of the adenine base, to activate adenylate cyclase and increase either lymphocyte or cardiac cell cAMP levels is consistent with the designation of the high anti conformation as being the conformation required for the activation of adenylate cyclase. An understanding of the glycosidic conformation required by the extracellular adenosine receptor of the adenosine molecule provides the basis for designing nucleoside analogs of adenosine that will exert a desired effect on cAMP levels. The avoidance of unwanted immunosuppressive or cardiotoxic effects can be arranged by structural changes that prohibit the high anti conformation.
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000262:Adenylyl Cyclases / Q000378:metabolism*; D004789:Enzyme Activation; D008968:Molecular Conformation; D013329:Structure-Activity Relationship
chemical_list: D000262:Adenylyl Cyclases; D000241:Adenosine
references.citation: J Biol Chem. 1974 Aug 25;249(16):5296-303
references.pmid: 4369127
references.citation: Proc Natl Acad Sci U S A. 1976 Jan;73(1):213-7
references.pmid: 1061119
references.citation: Antimicrob Agents Chemother (Bethesda). 1968;8:180-9
references.pmid: 5735360
references.citation: J Biol Chem. 1974 Oct 10;249(19):6119-24
references.pmid: 4425095
references.citation: J Biol Chem. 1974 Jan 10;249(1):59-65
references.pmid: 4358641
references.citation: Biochemistry. 1974 Apr 23;13(9):1920-4
references.pmid: 4365250
references.citation: J Biol Chem. 1971 Mar 25;246(6):1877-82
references.pmid: 4926550
references.citation: Life Sci II. 1972 Dec 8;11(23):1143-54
references.pmid: 4351979
references.citation: Lancet. 1972 Dec 16;2(7790):1316
references.pmid: 4117846
references.citation: J Infect Dis. 1974 Nov;130(5):549-52
references.pmid: 4371532
references.citation: Eur J Biochem. 1974 Feb 1;41(3):421-30
references.pmid: 4361644
references.citation: J Immunol. 1972 Jun;108(6):1526-34
references.pmid: 4337966
references.citation: Mol Pharmacol. 1970 Jan;6(1):13-23
references.pmid: 4354003
references.citation: Biochem Pharmacol. 1969 Sep;18(9):2115-22
references.pmid: 4310276
references.citation: J Biol Chem. 1976 Jul 25;251(14):4239-46
references.pmid: 932031
references.citation: Biochim Biophys Acta. 1975 Oct 9;404(2):202-13
references.pmid: 170974
references.citation: J Biol Chem. 1975 Jun 10;250(11):4239-45
references.pmid: 1126949
references.citation: J Biol Chem. 1975 Jul 10;250(13):5003-8
references.pmid: 1171095
references.citation: Prog Allergy. 1972;16:300-449
references.pmid: 4564107
references.citation: Fed Proc. 1974 Aug;33(8):1882-5
references.pmid: 4602113
references.citation: Biochemistry. 1973 Aug 14;12(17):3294-302
references.pmid: 4542512
references.citation: Cancer Res. 1974 Dec;34(12):3197-202
references.pmid: 4547679
references.citation: Cancer Res. 1973 Jan;33(1):94-103
references.pmid: 4509125
references.citation: FEBS Lett. 1976 Jul 1;66(1):102-6
references.pmid: 179893
references.citation: Proc Natl Acad Sci U S A. 1975 Mar;72(3):888-91
references.pmid: 165492
references.citation: Science. 1975 Mar 14;187(4180):957-9
references.pmid: 167434
references.citation: Mol Pharmacol. 1975 Sep;11(5):528-44
references.pmid: 170501
references.citation: J Neurochem. 1975 Dec;25(6):895-6
references.pmid: 173803
references.citation: J Clin Invest. 1976 Feb;57(2):274-82
references.pmid: 176177
references.citation: Biochem Pharmacol. 1974 Oct 1;23(19):2761-7
references.pmid: 4423608
references.citation: Biochem Biophys Res Commun. 1974 Apr 8;57(3):590-5
references.pmid: 4827825
references.citation: J Pediatr. 1974 Feb;84(2):173-7
references.pmid: 4810724
references.citation: J Clin Invest. 1974 Apr;53(4):1194-6
references.pmid: 4815083
references.citation: Science. 1973 Nov 23;182(4114):836-7
references.pmid: 4795749
references.citation: Antimicrob Agents Chemother. 1973 Apr;3(4):534-5
references.pmid: 4790608
references.citation: Biochem Biophys Res Commun. 1973 Nov 16;55(2):410-6
references.pmid: 4767309
references.citation: J Cell Sci. 1973 Sep;13(2):429-39
references.pmid: 4760594
references.citation: Transplant Proc. 1973 Mar;5(1):943-7
references.pmid: 4735211
references.citation: J Biol Chem. 1973 Jul 10;248(13):4782-5
references.pmid: 4718743
references.citation: Biochem Pharmacol. 1973 Feb 1;22(3):341-8
references.pmid: 4687131
references.citation: Cancer. 1971 Jul;28(1):89-98
references.pmid: 4938894
references.citation: Circ Res. 1971 Oct;29(4):375-84
references.pmid: 5315522
references.citation: FEBS Lett. 1975 Oct 1;57(3):223-33
references.pmid: 1102331
references.citation: J Clin Invest. 1976 Sep;58(3):654-66
references.pmid: 956393
references.citation: Science. 1976 Aug 13;193(4253):587-8
references.pmid: 959817
references.citation: Proc Natl Acad Sci U S A. 1976 Jan;73(1):104-8
references.pmid: 1061104
references.citation: Cancer Res. 1975 Jan;35(1):68-70
references.pmid: 1053696
references.citation: Ann N Y Acad Sci. 1975 Aug 8;255:380-9
references.pmid: 1059366
references.citation: Br J Cancer. 1975 May;31(5):544-9
references.pmid: 1057444
references.citation: J Biol Chem. 1976 Jul 10;251(13):4055-61
references.pmid: 932021
references.citation: Biochim Biophys Acta. 1976 Jun 18;435(2):132-44
references.pmid: 938674
references.citation: Am J Physiol. 1963 Feb;204:317-22
references.pmid: 13971060
references.citation: J Biol Chem. 1976 Nov 10;251(21):6791-7
references.pmid: 185219
references.citation: J Biol Chem. 1976 Nov 10;251(21):6757-66
references.pmid: 185217
references.citation: Biochem Pharmacol. 1976 Dec 15;25(24):2713-9
references.pmid: 188424
references.citation: Proc Natl Acad Sci U S A. 1976 Dec;73(12):4257-60
references.pmid: 1069980
references.citation: J Biol Chem. 1976 Oct 10;251(19):5839-44
references.pmid: 972142
references.citation: Lancet. 1972 Nov 18;2(7786):1067-9
references.pmid: 4117384
references.citation: Science. 1974 Apr 5;184(4132):19-28
references.pmid: 4131281
references.citation: Chem Pharm Bull (Tokyo). 1975 Apr;23(4):759-74
references.pmid: 1182861
references.citation: Antimicrob Agents Chemother. 1975 Feb;7(2):203-7
references.pmid: 1137371
references.citation: J Med Chem. 1971 May;14(5):415-20
references.pmid: 5117688
references.citation: J Immunol. 1971 Apr;106(4):917-26
references.pmid: 5553718
references.citation: Biochim Biophys Acta. 1971 Jun 30;240(2):170-9
references.pmid: 5559973
references.citation: Cancer Chemother Rep 2. 1968 Oct;1(1):1-272
references.pmid: 5743752
references.citation: Br J Pharmacol Chemother. 1966 Nov;28(2):218-27
references.pmid: 5972628
references.citation: Acta Crystallogr. 1965 Jul 10;19(1):111-24
references.pmid: 5896865
references.citation: J Exp Med. 1972 Jul 1;136(1):112-27
references.pmid: 4402392
references.citation: Life Sci. 1975 Oct 10;17(7):1021-38
references.pmid: 172752
references.citation: Eur J Pharmacol. 1972 Aug;19(2):246-50
references.pmid: 4403675
references.citation: Drug Metab Dispos. 1973 Jul-Aug;1(4):645-52
references.pmid: 4149639
references.citation: Biochem Biophys Res Commun. 1974 Feb 27;56(4):934-9
references.pmid: 4363643
references.citation: Life Sci. 1974 Feb 1;14(3):489-503
references.pmid: 4363081